For Physicians

Texas Heart Medical Group is proud to partner with you to provide outstanding cardiovascular care to your patient. Additionally, you may download and fax our most current referral form for your convenience.

Physician’s Referrals

Phone: (713) 790-9401
Fax : (713) 790-0353

Research Projects & Studies

Texas Heart Medical Group is committed to pushing the field of heart health forward. Read the latest in research and studies by our doctors.

Stem Cell Therapy vs Standard of Care in Cardiomyopathy (NCT02962661)

Randomized 3-Arm Trial with Standard of Care Alone vs either Intravenous Infusion or Transendocardial Injection of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) plus Standard of Care in Patients with Anthracycline-Associated Cardiomyopathy

GORE EXCLUDER (NCT02489539)

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

Houston HeartReach

The Houston HeartReach Registry is a community-wide registry research study that aims to make improvements in heart disease prevention, diagnosis, and treatment for all women to help identify trends in heart-health risks in a diverse population of women, develop future clinical trials, and recruit women for future research studies.

Recommended Publications

Texas Heart Medical Group is powered by Texas Heart Institute, so our doctors and staff are apprised of the latest in heart health treatments and ever-evolving technologies. Learn more about the vast and conditions we treat here at Texas Heart Medical Group.

Dr. Briana Costello Discusses Cardio-Pharmacology & Cardiac Rehab

Dr. Briana Costello discusses Cardio-Pharmacology and Cardiac Rehabilitation. Dr. Briana Costello is a general and interventional cardiologist at the Texas Heart Medical Group. She is an active member of the online medical community and passionate about women’s heart health.

Hemodynamic outcomes after valve-in-valve transcatheter aortic valve replacement: a single-center experience

ViV-TAVR is an effective option for treating degenerated surgical aortic bioprostheses, with acceptable hemodynamic outcomes. Small surgical valves and stented surgical valves are associated with higher postprocedural gradients.